查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1966062

全球合约研究组织（CRO）市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Contract Research Organization Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 153 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计合约研究组织 (CRO) 市场将从 2025 年的 962.5 亿美元成长到 2034 年的 2,022.4 亿美元，2026 年至 2034 年的复合年增长率为 8.6%。

受製药和生物技术研发活动日益活跃的推动，全球合约研究组织 (CRO) 市场正迅速扩张。药物研发的复杂性不断增加，监管要求也日益严格，促使企业将临床试验和实验室服务外包。 CRO 提供经济高效且扩充性的解决方案，帮助申办方在确保合规性的同时加快研发进度。生物製药、生物相似药和个人化医疗的蓬勃发展进一步强化了对专业研究能力的需求。新兴市场也因其多元化的患者群体和具有竞争力的营运成本，正成为极具吸引力的临床试验地点。

关键驱动因素包括研发支出激增、慢性病盛行率上升以及对高效试验管理的需求。製药公司正在扩大与合约研究组织 (CRO) 的策略合作，以优化资源配置并降低资本支出。分散式试验、电子数据采集和人工智慧分析等技术创新正在提高营运效率。此外，各地区监管协调的进展正在促进跨境临床研究，为全球 CRO服务供应商拓展市场机会。

随着精准医疗、细胞和基因疗法以及罕见疾病研究的拓展，未来前景依然光明。涵盖临床前到上市后阶段的综合服务模式的需求预计将会成长。数位健康工具和远端监测解决方案有望重塑临床试验方法。在竞争日益激烈的背景下，专注于治疗领域专业知识、先进数据管理以及开拓新兴市场的合约研究组织（CRO）将更有利于实现可持续的长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球合约研究组织 (CRO) 市场：按类型划分

  • 市场分析、洞察与预测
  • 早期开发服务（化学、製造、品管（CMC）、非临床试验服务、药物发现）
  • 临床试验（1期、2期、3期、4期）
  • 实验室服务
  • 其他的

第五章：全球合约研究组织 (CRO) 市场：按应用划分

  • 市场分析、洞察与预测
  • 肿瘤学
  • 神经病学
  • 心臟病学
  • 感染疾病
  • 代谢性疾病
  • 肾臟病学/肾臟病学
  • 其他的

第六章：全球合约研究组织（CRO）市场：依最终使用者划分

  • 市场分析、洞察与预测
  • 製药和生物技术公司
  • 医疗设备製造商
  • 学术研究机构
  • 其他的

第七章 全球合约研究组织 (CRO) 市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medpace
    • Laboratory Corporation Of America Holdings
    • ICON Plc
    • IQVIA Inc
    • Syneos Health
    • Novotech
    • KCR SA
    • Ergomed Group
    • Thermo Fisher Scientific Inc
    • WuXi Biologics
    • Tigermed
    • Worldwide Clinical Trials
    • Charles River Laboratories
    • Microbiologics
    • Parexel International（MA）Corporation
简介目录
Product Code: VMR11210235

The Contract Research Organization Market size is expected to reach USD 202.24 Billion in 2034 from USD 96.25 Billion (2025) growing at a CAGR of 8.6% during 2026-2034.

The Global Contract Research Organization (CRO) Market has expanded rapidly alongside rising pharmaceutical and biotechnology research activities. Increasing drug development complexity and stringent regulatory requirements have encouraged companies to outsource clinical trials and laboratory services. CROs provide cost-effective, scalable solutions that help sponsors accelerate timelines and maintain compliance. Growth in biologics, biosimilars, and personalized medicine has further strengthened demand for specialized research expertise. Emerging markets have also become attractive destinations for clinical trials due to diverse patient pools and competitive operational costs.

Key drivers include the surge in R&D spending, growing prevalence of chronic diseases, and the need for efficient trial management. Pharmaceutical firms increasingly adopt strategic partnerships with CROs to optimize resources and reduce capital expenditure. Technological advancements such as decentralized trials, electronic data capture, and AI-powered analytics enhance operational efficiency. Additionally, regulatory harmonization across regions has facilitated cross-border clinical studies, broadening market opportunities for global CRO service providers.

Future prospects remain promising as precision medicine, cell and gene therapies, and rare disease research expand. Demand for integrated service models covering preclinical to post-marketing phases is expected to rise. Digital health tools and remote monitoring solutions will likely reshape trial methodologies. As competition intensifies, CROs focusing on therapeutic specialization, advanced data management, and emerging market penetration are well-positioned to achieve sustained long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Early Phase Development Services (Chemistry, Manufacturing, and Controls (CMC), Preclinical Service, Discovery)
  • Clinical (Phase 1, Phase 2, Phase 3, Phase 4)
  • Laboratory Service
  • Others

By Application

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Disease
  • Metabolic Disorder
  • Renal/Nephrology
  • Others

By End-user

  • Pharmaceutical & Biotechnological Companies
  • Medical Device Companies
  • Academic & Research Institutes
  • Others

COMPANIES PROFILED

  • Medpace, Laboratory Corporation of America Holdings, ICON plc, IQVIA Inc, Syneos Health, Novotech, KCR SA, Ergomed Group, Thermo Fisher Scientific Inc, WuXi Biologics, Tigermed, Worldwide Clinical Trials, Charles River Laboratories, Microbiologics, Parexel International MA Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Early Phase Development Services (Chemistry, Manufacturing, and Controls (CMC), Preclinical Service, Discovery) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Clinical (Phase 1, Phase 2, Phase 3, Phase 4) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Laboratory Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Metabolic Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Renal/Nephrology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Pharmaceutical & Biotechnological Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Application
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Application
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Application
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Application
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Application
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CONTRACT RESEARCH ORGANIZATION INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medpace
    • 9.2.2 Laboratory Corporation Of America Holdings
    • 9.2.3 ICON Plc
    • 9.2.4 IQVIA Inc
    • 9.2.5 Syneos Health
    • 9.2.6 Novotech
    • 9.2.7 KCR S.A
    • 9.2.8 Ergomed Group
    • 9.2.9 Thermo Fisher Scientific Inc
    • 9.2.10 WuXi Biologics
    • 9.2.11 Tigermed
    • 9.2.12 Worldwide Clinical Trials
    • 9.2.13 Charles River Laboratories
    • 9.2.14 Microbiologics
    • 9.2.15 Parexel International (MA) Corporation